Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis | NEJM
Fibrosi polmonare idiopatica: su NEJM studio su una nuova terapia, coordinato da Luca Richeldi - Policlinico Universitario A. Gemelli IRCCS
Daniel Meyerkort on LinkedIn: #exercise #jointreplacement #tkr #diet #prehab
Monumen-TAL - I dismantle the ASH/ NEJM Talquetamab study | First of the ASH 2022 video series - YouTube
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM
Cost-Effectiveness of Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer in: Journal of the National Comprehensive Cancer Network Volume 18 Issue 11 (2020)
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma | NEJM
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM
10 1056@NEJMoa2028220 PDF | PDF | Myocardial Infarction | High Density Lipoprotein
Genes | Free Full-Text | Personalized Systemic Therapies in Hereditary Cancer Syndromes
GD2-CART01 for Relapsed or Refractory High-Risk Neuroblastoma | NEJM
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease | NEJM
PDF) Olaparib Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Serous Ovarian Cancer
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer | NEJM
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer | NEJM
A che punto siamo con gli studi clinici randomizzati controllati (RCT)? - Area Farmacisti - Farmacie Comunali Riunite
Monumen-TAL - I dismantle the ASH/ NEJM Talquetamab study | First of the ASH 2022 video series - YouTube
Current Oncology | Free Full-Text | Olaparib versus Placebo in Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer: A Cost–Utility Analysis from the Canadian Public Payer’s Perspective
Cancer Clinical Trial Interpretation Videos - YouTube
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer | NEJM
